Raymond James analyst David Rodgers resumed coverage of Healthcare Realty Trust with an Outperform rating and $24 price target. Despite strong returns since CEO Pete Scott's arrival, the stock continues to possess "strong value for investors" as occupancy upside and redevelopment leasing should each result in improved earnings, cash flow and dividend growth, the analyst tells investors.
